Currently out of the existing stock ratings of Joseph Stringer, 142 are a BUY (97.26%), 4 are a HOLD (2.74%).

Joseph Stringer

Work Performance Price Targets & Ratings Chart

Analyst Joseph Stringer works at NEEDHAM with a stock forecast success ratio of 28.11% fulfilled within 107.11 days on average.

Joseph Stringer’s has documented 284 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PHAT, Phathom Pharmaceuticals at 19-Apr-2024.

Wall Street Analyst Joseph Stringer

Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for STOK (STOKE THERAPEUTICS) at 2/16/2024. The price target of $14 was fulfilled within 40 days with a profit of $8.73 (165.65%) receiving and performance score of 41.41.

Average potential price target upside

of $33.97 (20.9%) on ALNY (ALNYLAM PHARMACEUTICALS).
of $20.1 (50.91%) on APLS (APELLIS PHARMACEUTICALS).
of $11.11 (69.79%) on RYTM (RHYTHM PHARMACEUTICALS).

APLS Apellis Pharmaceuticals INZY Inozyme Pharma ACAD ACADIA Pharmaceuticals ALNY Alnylam Pharmaceuticals ANNX Annexon ICPT Intercept Pharmaceuticals TBPH Theravance Biopharma ARNA Arena Pharmaceuticals RYTM Rhythm Pharmaceuticals VIR Vir Biotechnology STOK Stoke Therapeutics PHAT Phathom Pharmaceuticals CARA Cara Therapeutic IONS Ionis Pharmaceuticals PCVX Vaxcyte PLRX Pliant Therapeutics RNA Avidity Biosciences CDTX Cidara Therapeutics ZEAL Zealand Pharma A/S ADR

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Laura Chico (WEDBUSH)